Molecular Signatures of Cardiovascular Disease Risk: Potential for Test Development and Clinical Application

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.12, Iss.5, 2008-01, pp. : 281-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential for CETP inhibition to reduce cardiovascular disease risk

By Ansell Benjamin Hobbs F. D. Richard

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2467-2478

Informa Healthcare

Access to resources Recommend Favorite

Metformin and Risk of Cardiovascular Disease

Cardiology, Vol. 91, Iss. 3, 1999-09 ,pp. : 203-204

Karger

Access to resources Recommend Favorite

Therapeutic potential of midkine in cardiovascular disease

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular disease risk of homeless patients

By Maxwell Janet Lie Jason

British Journal of General Practice, Vol. 58, Iss. 554, 2008-09 ,pp. : 648-649

Royal College of General Practitioners

Access to resources Recommend Favorite

Evaluation of the Potential Role of Alirocumab in the Management of Hypercholesterolemia in Patients with High‐Risk Cardiovascular Disease

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 8, 2015-08 ,pp. : 771-779

John Wiley & Sons Inc

Access to resources Recommend Favorite